Brown Brothers Harriman & Co’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.1M Buy
257,653
+17,815
+7% +$2.09M 0.15% 104
2026
Q1
$28.9M Buy
239,838
+9,479
+4% +$1.09M 0.15% 96
2025
Q4
$24.2M Buy
230,359
+14,804
+7% +$1.39M 0.13% 98
2025
Q3
$18.1M Buy
215,555
+7,463
+4% +$615K 0.11% 101
2025
Q2
$16.5M Sell
208,092
-3,425
-2% -$272K 0.11% 98
2025
Q1
$19M Sell
211,517
-16,505
-7% -$1.54M 0.13% 94
2024
Q4
$22.7M Sell
228,022
-6,432
-3% -$663K 0.16% 85
2024
Q3
$26.6M Buy
234,454
+420
+0.2% +$49.9K 0.18% 78
2024
Q2
$29M Buy
234,034
+3,127
+1% +$403K 0.22% 53
2024
Q1
$30.5M Sell
230,907
-286
-0.1% -$35.3K 0.23% 53
2023
Q4
$25.2M Sell
231,193
-32,555
-12% -$3.38M 0.21% 53
2023
Q3
$27.2M Sell
263,748
-6,158
-2% -$664K 0.24% 51
2023
Q2
$31.1M Sell
269,906
-2,968
-1% -$337K 0.25% 51
2023
Q1
$29M Sell
272,874
-1,521
-0.6% -$164K 0.24% 50
2022
Q4
$30.4M Sell
274,395
-6,167
-2% -$630K 0.27% 51
2022
Q3
$24.2M Sell
280,562
-18,289
-6% -$1.63M 0.22% 56
2022
Q2
$27.2M Buy
298,851
+676
+0.2% +$59.9K 0.23% 57
2022
Q1
$24.5M Sell
298,175
-11,693
-4% -$922K 0.17% 59
2021
Q4
$23.7M Sell
309,868
-25,162
-8% -$2M 0.13% 67
2021
Q3
$25.2M Sell
335,030
-7,644
-2% -$581K 0.15% 64
2021
Q2
$26.6M Sell
342,674
-20,090
-6% -$1.49M 0.16% 64
2021
Q1
$26.7M Sell
362,764
-20,497
-5% -$1.51M 0.17% 65
2020
Q4
$29.9M Buy
383,261
+5,986
+2% +$458K 0.2% 58
2020
Q3
$29.9M Sell
377,275
-12,386
-3% -$970K 0.21% 58
2020
Q2
$28.8M Sell
389,661
-79
-0% -$5.95K 0.22% 57
2020
Q1
$28.6M Sell
389,740
-9,798
-2% -$770K 0.23% 56
2019
Q4
$34.7M Buy
399,538
+363
+0.1% +$29.8K 0.22% 57
2019
Q3
$32.1M Buy
399,175
+53,112
+15% +$4.26M 0.21% 58
2019
Q2
$27.7M Buy
346,063
+8,532
+3% +$653K 0.18% 57
2019
Q1
$26.8M Sell
337,531
-4,750
-1% -$355K 0.18% 56
2018
Q4
$25M Buy
342,281
+4,404
+1% +$311K 0.19% 55
2018
Q3
$22.9M Buy
337,877
+109,832
+48% +$7M 0.14% 54
2018
Q2
$13.2M Buy
228,045
+3,585
+2% +$202K 0.08% 66
2018
Q1
$11.7M Sell
224,460
-3,757
-2% -$203K 0.07% 68
2017
Q4
$12.3M Buy
228,217
+1,607
+0.7% +$89.1K 0.07% 68
2017
Q3
$13.8M Buy
226,610
+44,708
+25% +$2.71M 0.07% 62
2017
Q2
$11.1M Sell
181,902
-37,707
-17% -$2.3M 0.06% 62
2017
Q1
$13.3M Buy
219,609
+157
+0.1% +$9.53K 0.07% 61
2016
Q4
$12.3M Sell
219,452
-7,263
-3% -$425K 0.07% 67
2016
Q3
$13.5M Buy
226,715
+4,949
+2% +$289K 0.07% 60
2016
Q2
$12.2M Sell
221,766
-10,030
-4% -$534K 0.06% 65
2016
Q1
$11.7M Sell
231,796
-10,683
-4% -$523K 0.06% 63
2015
Q4
$12.2M Sell
242,479
-3,323
-1% -$168K 0.06% 65
2015
Q3
$11.6M Sell
245,802
-4,049
-2% -$215K 0.06% 66
2015
Q2
$13.6M Buy
249,851
+48,916
+24% +$2.74M 0.06% 61
2015
Q1
$11M Sell
200,935
-18,921
-9% -$1.07M 0.05% 70
2014
Q4
$11.9M Sell
219,856
-2,387
-1% -$133K 0.05% 71
2014
Q3
$12.6M Sell
222,243
-4,518
-2% -$254K 0.05% 68
2014
Q2
$12.5M Buy
226,761
+5,811
+3% +$317K 0.05% 71
2014
Q1
$12M Sell
220,950
-234,029
-51% -$12.1M 0.05% 68
2013
Q4
$21.7M Buy
454,979
+224,571
+97% +$10.3M 0.05% 70
2013
Q3
$10.5M Sell
230,408
-135,412
-37% -$6.18M 0.05% 68
2013
Q2
$16.2M Buy
+365,820
New +$16.3M 0.08% 62

Other funds holding MRK

Brown Brothers Harriman & Co's MRK Position: Q2 2026 in Review

Brown Brothers Harriman & Co increased its Merck (MRK) stake by 7.4% in Q2 2026, buying an estimated $2.09M and bringing the position to 257,653 shares worth $33.1M. The position accounts for 0.15% of the portfolio, ranked #104.

Brown Brothers Harriman & Co first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $34.7M in Q4 2019. 3,828 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Brown Brothers Harriman & Co held 257,653 shares of Merck worth $33.1M as of Q2 2026.
  • Brown Brothers Harriman & Co bought 17,815 Merck shares in Q2 2026, an estimated $2.09M.
  • Merck made up 0.15% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #104 holding.
  • Brown Brothers Harriman & Co first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Brown Brothers Harriman & Co's Merck position peaked at $34.7M in Q4 2019.
  • 3,828 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.